JP2004224775A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004224775A5 JP2004224775A5 JP2003017909A JP2003017909A JP2004224775A5 JP 2004224775 A5 JP2004224775 A5 JP 2004224775A5 JP 2003017909 A JP2003017909 A JP 2003017909A JP 2003017909 A JP2003017909 A JP 2003017909A JP 2004224775 A5 JP2004224775 A5 JP 2004224775A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- agent according
- inflammatory agent
- inflammatory
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003017909A JP2004224775A (ja) | 2003-01-27 | 2003-01-27 | 抗炎症剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003017909A JP2004224775A (ja) | 2003-01-27 | 2003-01-27 | 抗炎症剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004224775A JP2004224775A (ja) | 2004-08-12 |
JP2004224775A5 true JP2004224775A5 (US20050137174A1-20050623-C00027.png) | 2006-02-09 |
Family
ID=32904933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003017909A Pending JP2004224775A (ja) | 2003-01-27 | 2003-01-27 | 抗炎症剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2004224775A (US20050137174A1-20050623-C00027.png) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007007985A2 (en) * | 2005-07-07 | 2007-01-18 | Postech Foundation | Ligand of regulating immune response, and use thereof in treating an immune response-related disease |
CA2730615A1 (en) * | 2008-07-18 | 2010-01-21 | Galderma Research & Development | Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them |
JP7328696B2 (ja) | 2018-01-30 | 2023-08-17 | Shiodaライフサイエンス株式会社 | 角膜上皮細胞走化促進剤 |
EP3932490A4 (en) * | 2019-02-27 | 2022-11-16 | Kagoshima University | ANTIPRURIC AGENT USING PAC1 RECEPTOR ANTAGONISTS |
-
2003
- 2003-01-27 JP JP2003017909A patent/JP2004224775A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2004515500A5 (US20050137174A1-20050623-C00027.png) | ||
JP2004532810A5 (US20050137174A1-20050623-C00027.png) | ||
JP2004529078A5 (US20050137174A1-20050623-C00027.png) | ||
JP2004523498A5 (US20050137174A1-20050623-C00027.png) | ||
JP2006503588A5 (US20050137174A1-20050623-C00027.png) | ||
ITTO20000779A0 (it) | Composizioni farmaceutiche. | |
IL182632A0 (en) | Benzene derivatives having at least 2 substituents and pharmaceutical compositions containing the same | |
PT1501534E (pt) | Formulacoes farmaceuticas | |
NO20052306D0 (no) | Dispergerbare farmasoytiske blandinger. | |
ITMI20011337A0 (it) | Composizioni farmaceutiche orali a rilascio modificato del principio attivo | |
DK1524266T3 (da) | Farmaceutisk sammensætning | |
ATE328584T1 (de) | In der mundhöhle schnell zerfallende orale feste verabreichungsform | |
JP2003503454A5 (US20050137174A1-20050623-C00027.png) | ||
DK1467724T3 (da) | Farmaceutisk sammensætning med agomelatin til dispergering i mundhulen | |
DE60118008D1 (de) | Pharmazeutische zusammensetzungen mit amlodipinmaleat | |
JP2008515980A5 (US20050137174A1-20050623-C00027.png) | ||
IS7051A (is) | Lyfjasamsetningar | |
JP2005509503A5 (US20050137174A1-20050623-C00027.png) | ||
DE60305728D1 (de) | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERLuNGERTER FREISETZUNG | |
ITMI20011338A0 (it) | Composizioni farmaceutiche orali a rilascio immediato del principio attivo | |
FR2802423B1 (fr) | Compositions pharmaceutiques | |
FI20022128A (fi) | Farmaseuttinen koostumus | |
ITRM20030363A0 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. | |
DK1225902T3 (da) | Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden | |
DE60217390D1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung |